Graphite Bio Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Graphite Bio is a clinical-stage biotechnology company developing next-generation gene editing therapies for a range of serious diseases. It pursues a precision approach to find and replace genes by guiding DNA repair to correct mutations or insert functional genes at defined locations. The company is also advancing conditioning regimens to broaden access to potentially curative therapies, and it was co-founded by Maria Grazia Roncarolo and Matthew Porteus.

Headquartered in South San Francisco, California, Graphite Bio operates in the biotechnology research industry and targets patients with genetic diseases that could benefit from targeted gene editing. A notable development in late 2023 was its merger with LENZ Therapeutics in an all-stock transaction.

Sign up for free to view info

Company overview Employee directory